Cost-effectiveness of pemetrexed in combination with cisplatin as first line treatment for patients with advanced non-squamous non-small-cell

• Main Authors: Jonathan González García (Author), Fernando Gutiérrez Nicolás (Author), Gloria Julia Nazco Casariego (Author), Cristina Valcárcel Nazco (Author), Jose Norberto Batista López (Author), Juana Oramas Rodríguez (Author)
• Format: Book
• Published: Elsevier, 2017-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Introduction: Lung cancer is the third most frequent neoplastic tumour in Spain, with around 27 000 new cases diagnosed per year; 80-95% of these are non-small-cell cancer (NSCLC), and the majority of cases are diagnosed in advanced stages of the disease, and for this reason it is one of the oncolog...